Imaging expression of prostate-specific membrane antigen and response to PSMA-targeted beta-emitting radionuclide therapies in metastatic castration-resistant prostate cancer

BACKGROUND: Prostate-specific membrane antigen (PSMA)-targeted radionuclide therapy (TRT) has demonstrated efficacy and tolerability with a dose-response effect in phase I/II trials in men with metastatic castration-resistant prostate cancer (mCRPC). The need for positive PSMA imaging prior to PSMA-...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Prostate
Main Authors: Vlachostergios, Panagiotis J., Niaz, Muhammad Junaid, Skafida, Myrto, Mosallaie, Seyed Ali, Thomas, Charlene, Christos, Paul J., Osborne, Joseph R., Molina, Ana M., Nanus, David M., Bander, Neil Harrison, Tagawa, Scott T.
Formato: Artigo
Idioma:Inglês
Publicado em: 2021
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7904644/
https://ncbi.nlm.nih.gov/pubmed/33465252
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/pros.24104
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados